These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 6309278)

  • 41. Inhibition of endothelial cell-mediated generation of activated protein C by direct and antithrombin-dependent thrombin inhibitors.
    Linder R; Frebelius S; Jansson K; Swedenborg J
    Blood Coagul Fibrinolysis; 2003 Feb; 14(2):139-46. PubMed ID: 12632023
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of thrombin-antithrombin complex (TAT) levels and fibrinopeptide A following thrombin incubation of human plasma using hirudin as an inhibitor of TAT formation.
    Haaland AK; Skjønsberg OH; Gravem K; Ruyter R; Godal HC
    Thromb Res; 1991 Feb; 61(3):253-9. PubMed ID: 2028444
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inhibition of coagulation and thrombin-induced platelet activities by a synthetic dodecapeptide modeled on the carboxy-terminus of hirudin.
    Jakubowski JA; Maraganore JM
    Blood; 1990 Jan; 75(2):399-406. PubMed ID: 2294999
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The kinetics, function, and regulation of P-selectin expressed by human brain microvessel endothelial cells in primary culture.
    Easton AS; Dorovini-Zis K
    Microvasc Res; 2001 Nov; 62(3):335-45. PubMed ID: 11678636
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inhibition of thrombin by hirudin genetically fused to wild-type or mutant antithrombin.
    Syed S; Kelly KE; Sheffield WP
    Thromb Res; 1996 Dec; 84(6):419-29. PubMed ID: 8987163
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Uptake and inactivation of thrombin by the fresh, glutardialdehyde or heparin treated human umbilical cord vein endothelium.
    Björck C; Larsson R; Olsson P; Rothman U
    Thromb Res; 1981 Mar; 21(6):603-9. PubMed ID: 6791299
    [No Abstract]   [Full Text] [Related]  

  • 47. Thrombin-induced release of active basic fibroblast growth factor-heparan sulfate complexes from subendothelial extracellular matrix.
    Benezra M; Vlodavsky I; Ishai-Michaeli R; Neufeld G; Bar-Shavit R
    Blood; 1993 Jun; 81(12):3324-31. PubMed ID: 8507869
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Potential advantages of direct-acting thrombin inhibitors.
    Philippides GJ; Loscalzo J
    Coron Artery Dis; 1996 Jul; 7(7):497-507. PubMed ID: 8913677
    [No Abstract]   [Full Text] [Related]  

  • 49. Inhibition by beraprost sodium of thrombin-induced increase in endothelial macromolecular permeability.
    Imai-Sasaki R; Kainoh M; Ogawa Y; Ohmori E; Asai Y; Nakadate T
    Prostaglandins Leukot Essent Fatty Acids; 1995 Aug; 53(2):103-8. PubMed ID: 7480071
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Control of proliferation of human vascular endothelial cells. Characterization of the response of human umbilical vein endothelial cells to fibroblast growth factor, epidermal growth factor, and thrombin.
    Gospodarowicz D; Brown KD; Birdwell CR; Zetter BR
    J Cell Biol; 1978 Jun; 77(3):774-88. PubMed ID: 308066
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tumor necrosis factor decreases thrombin receptor expression in endothelial cells.
    Yan W; Tiruppathi C; Qiao R; Lum H; Malik AB
    J Cell Physiol; 1996 Mar; 166(3):561-7. PubMed ID: 8600159
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Thrombin-hirudin complex stability: a comparison with the thrombin-antithrombin III complex.
    Römisch J; Pâques EP
    Blood Coagul Fibrinolysis; 1991 Oct; 2(5):643-6. PubMed ID: 1782334
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Measurement of intracellular calcium concentration in intact monolayers of human endothelial cells.
    Wickham NW; Vercellotti GM; Moldow CF; Visser MR; Jacob HS
    J Lab Clin Med; 1988 Aug; 112(2):157-67. PubMed ID: 2840476
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Role of cyclic AMP in promoting the thromboresistance of human endothelial cells by enhancing thrombomodulin and decreasing tissue factor activities.
    Archipoff G; Beretz A; Bartha K; Brisson C; de la Salle C; Froget-Léon C; Klein-Soyer C; Cazenave JP
    Br J Pharmacol; 1993 May; 109(1):18-28. PubMed ID: 7684300
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inactivation of alpha- and beta- thrombin by antithrombin-III and heparin.
    Machovich R; Blaskó G; Borsodi A
    Thromb Haemost; 1976 Dec; 36(3):503-8. PubMed ID: 65798
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Coagulant and noncoagulant thrombin enzymatic activity on the endothelium.
    Frebelius S; Nydahl S; Swedenborg J
    Blood Coagul Fibrinolysis; 1990 Aug; 1(3):285-92. PubMed ID: 2103313
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Thrombin downregulates thrombomodulin expression and activity in primary human endothelial cells.
    Séguin C; Abid MR; Spokes KC; Aird WC
    Endothelium; 2008; 15(3):143-8. PubMed ID: 18568955
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of vasoactive agonists on the membrane potential of cultured bovine aortic and guinea-pig coronary endothelium.
    Mehrke G; Pohl U; Daut J
    J Physiol; 1991 Aug; 439():277-99. PubMed ID: 1895239
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Thrombin stimulates production of interleukin-8 in human umbilical vein endothelial cells.
    Ueno A; Murakami K; Yamanouchi K; Watanabe M; Kondo T
    Immunology; 1996 May; 88(1):76-81. PubMed ID: 8707354
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antithrombin III inhibits thrombin-induced proliferation in human arterial smooth muscle cells.
    Hedin U; Frebelius S; Sanchez J; Dryjski M; Swedenborg J
    Arterioscler Thromb; 1994 Feb; 14(2):254-60. PubMed ID: 8305417
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.